On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...